Neuro-Oncology
Click on the sign to list the poster and platform presentations by year. Then click on the link to view that presentation.
2022
<2021
- An innovative virtual multi-institutional, multidisciplinary neuro-oncology tumor board: The NIH-NOB experience during the COVID-19 pandemic.
- IDH mutation status and the development of venous thromboembolism in astrocytoma patients.
- Treatment strategies for glioblastoma in older patients: Age is just a number.
- Examining the impact of isocitrate dehydrogenase (IDH) gene status on the development of venous thromboembolism in glioma patients.
- Effect of health disparities on overall survival of patients with glioblastoma.
- Window-of-opportunity clinical trial of a PD-1 inhibitor in patients with recurrent glioblastoma.
- Effect of health disparities on overall survival of patients with glioblastoma.
- Spinal dural arteriovenous fistula and concomitant intramedullary spinal lesion.
- Vision impairment and papilledema as the initial manifestation of neurosyphilis in a young immunocompetent patient.
- Impact of IDH-1 mutation status on outcome in clinical trials for recurrent glioblastoma.
- Adverse effects of bevacizumab in brain tumor patients.
- Venous thromboembolism (VTE) and glioblastoma.
- Improved progression free survival in 1p/19q co-deleted anaplastic oligodendroglioma treated with both chemotherapy and radiation therapy at diagnosis.
[Platform Presentation]
- Survival outcomes of patients with recurrent anaplastic glioma treated with bevacizumab.
- Glioblastoma and leptomeningeal dissemination.
- Tosedostat and posterior reversible encephalopathy syndrome (PRES).
[Oral Presentation]
- Severe neurological disability in cancer patients acutely infected with the West Nile virus (WNV).
- Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.
- Sporadic CJD (VV2 Type) presenting with central vestibular abnormalities.
- Early predictors of progression in idiopathic sensory neuropathy.
Society of Neuro-Oncology (SNO)
26th Annual Scientific Meeting and Education Day in Boston, Mass. (Nov. 18-21, 2021)
Society of Neuro-Oncology (SNO)
25th Virtual Annual Scientific Meeting and Education Day (Nov. 19-21, 2020)
American Academy of Neurology (AAN)
72nd Annual Meeting in Toronto, Ontario, Canada (April 25 - May 1, 2020)
Society of Neuro-Oncology (SNO)
23rd Annual Scientific Meeting and Education Day in New Orleans, La. (Nov. 15-18, 2018)
American Society of Clinical Oncology (ASCO)
54th Annual Meeting in Chicago, Ill. (June 1-5, 2018)
American Academy of Neurology (AAN)
70th Annual Meeting in Los Angeles, Calif. (April 21-27, 2018)
American Academy of Neurology (AAN)
68th Annual Meeting in Vancouver, BC, Canada (April 15-21, 2016)
American Society of Clinical Oncology (ASCO)
51st Annual Meeting in Chicago, Ill. (May 29 - June 2, 2015)
American Society of Clinical Oncology (ASCO)
50th Annual Meeting in Chicago, Ill. (May 30 - June 3, 2014)
American Academy of Neurology (AAN)
66th Annual Meeting in Philadelphia, Penn. (April 26 - May 3, 2014)
Society of Neuro-Oncology (SNO)
18th Annual Meeting in San Francisco, Calif. (Nov. 21-24, 2013)
European Neurological Society (ENS)
23rd Annual Meeting in Barcelona, Spain (June 8-11, 2013)
American Society of Clinical Oncology (ASCO)
49th Annual Meeting in Chicago, Ill. (May 31 - June 4, 2013)
American Academy of Neurology (AAN)
64th Annual Meeting in New Orleans, La. (April 21-28, 2012)